Education
About Us
Working with TipRanks
Follow Us
James Mackin Insider Profile
4 Followers
James Mackin, President & CEO at Artivion, holds 852.78K shares in Artivion (Ticker: AORT), holds 11.72K shares in Wright Medical Group (Ticker: WMGI), holds 97.79K shares in Medtronic (Ticker: MDT). Most recently, James Mackin Sold ― shares of Artivion on Aug 19, 2025 for an estimated value of $528.88K.
Profitable Transactions
4 out of 11 Profitable Transactions
Average Return
-12.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that James Mackin holds in companies
Most Profitable Insider Trade
The most profitable trade made by James Mackin
James Mackin's Trading History
Artivion
Aug 19, 2025
President & CEO
Informative Sell
528.88K
$36.69M
Wright Medical Group
Jul 30, 2019
―
Uninformative Buy
―
$351.37K
Medtronic
Nov 02, 2010
SVP & Pres CRDM
Uninformative Sell
93.18K
$9.12M
List of latest transactions for each holding click on a transaction to see James Mackin's performance on stock
You May Also Like
James Mackin insider profile FAQ
What is the percentage of profitable transactions made by James Mackin?
The percentage of profitable transactions made by James Mackin is 36%.
What is the average return per transaction made by James Mackin?
The average return per transaction made by James Mackin is -12.80%.
What stocks does James Mackin hold?
James Mackin holds: AORT, WMGI, MDT stocks.
What was James Mackin’s latest transaction?
James Mackin latest transaction was an Informative Sell of $528.88K.
What was James Mackin's most profitable transaction?
James Mackin’s most profitable transaction was an Informative Buy of AORT stock on March 4, 2016. The return on the trade was 50.00%.
What is James Mackin's role in Artivion?
James Mackin's role in Artivion is President & CEO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.